Article Text

The use of fibrin adhesive in trabeculectomy: a pilot study
  1. I Bahar,
  2. M Lusky,
  3. D Gaton,
  4. A Robinson,
  5. R Avisar,
  6. D Weinberger
  1. Department of Ophthalmology, Rabin Medical Center, Petah Tiqwa, Israel
  1. Correspondence to: I Bahar Department of Ophthalmology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa 49100, Israel; iritbahar{at}

Statistics from

During trabeculectomy, tight suturing of the scleral flap to avoid overfiltration may pose a risk of increased intraocular pressure (IOP) and a flat non-functioning bleb. Furthermore, the nylon sutures usually used to reattach the conjunctiva to the limbus may tear out of the conjunctiva and induce an inflammatory reaction. To overcome these problems, investigators have suggested the use of laser suture lysis1 or releasable sutures2 or other types of closure methods, such as staples, tapes and adhesives.3

Quixil (Omrix Biopharmaceuticals, Ramat Gan, Israel) is a human fibrin sealant consisting of two biological components that form a clot within 30 s of placement on the tissue surface. The clot promotes collagen crosslinking and, consequently, wound healing, and is absorbed after a few days. The aim of this study was to determine whether our good preliminary results with Quixil in an animal model could be extrapolated to human eyes.

Brief report

The study group consisted of five …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.